Association of Single-Nucleotide Variants in the Human Leukocyte Antigen and Other Loci With Childhood Hodgkin Lymphoma
Sign Up to like & getrecommendations! Published in 2022 at "JAMA Network Open"
DOI: 10.1001/jamanetworkopen.2022.25647
Abstract: Key Points Question What genetic variants or genes are associated with the risk of childhood Hodgkin lymphoma? Findings In this genetic association study nested within 3 childhood cancer survivor cohorts, 3 independent single-nucleotide variants (SNVs,… read more here.
Keywords: nucleotide variants; hodgkin lymphoma; childhood; single nucleotide ... See more keywords
Late Cardiac Toxic Effects Associated With Treatment Protocols for Hodgkin Lymphoma in Children
Sign Up to like & getrecommendations! Published in 2024 at "JAMA Network Open"
DOI: 10.1001/jamanetworkopen.2023.51062
Abstract: Key Points Question What is the risk of cardiac toxic effects associated with therapies used in pediatric Hodgkin lymphoma (HL) trials? Findings In this cohort study of 2563 patients with HL treated in 4 consecutive… read more here.
Keywords: cardiac toxic; late cardiac; toxic effects; effects associated ... See more keywords
Pembrolizumab Added to Ifosfamide, Carboplatin, and Etoposide Chemotherapy for Relapsed or Refractory Classic Hodgkin Lymphoma: A Multi-institutional Phase 2 Investigator-Initiated Nonrandomized Clinical Trial.
Sign Up to like & getrecommendations! Published in 2023 at "JAMA oncology"
DOI: 10.1001/jamaoncol.2022.7975
Abstract: Importance To our knowledge, this is the first clinical trial designed to investigate concurrent treatment with a checkpoint inhibitor and conventional chemotherapy in relapsed or refractory classic Hodgkin lymphoma in patients destined for an autologous… read more here.
Keywords: hodgkin lymphoma; relapsed refractory; refractory classic; chemotherapy ... See more keywords
Comprehensive Bridging Radiotherapy for Limited Pre-CART Non-Hodgkin Lymphoma.
Sign Up to like & getrecommendations! Published in 2024 at "JAMA oncology"
DOI: 10.1001/jamaoncol.2024.1113
Abstract: This cohort study examines the role of comprehensive bridging radiotherapy in the setting of chimeric antigen receptor T-cell therapy for non-Hodgkin lymphoma. read more here.
Keywords: non hodgkin; bridging radiotherapy; hodgkin lymphoma; comprehensive bridging ... See more keywords
Hodgkin lymphoma: A 2020 update on diagnosis, risk‐stratification, and management
Sign Up to like & getrecommendations! Published in 2020 at "American Journal of Hematology"
DOI: 10.1002/ajh.25856
Abstract: Hodgkin lymphoma (HL) is an uncommon B‐cell lymphoid malignancy affecting 8480 new patients annually and representing approximately 10% of all lymphomas in the United States. read more here.
Keywords: lymphoma; diagnosis risk; 2020 update; hodgkin lymphoma ... See more keywords
Eosinophil morphology in the reactive eosinophilia of Hodgkin lymphoma
Sign Up to like & getrecommendations! Published in 2021 at "American Journal of Hematology"
DOI: 10.1002/ajh.26337
Abstract: A 35-year-old woman with stage IVB refractory Hodgkin lymphoma, mixed cell type, who had initially presented 18 months earlier, developed marked leukocytosis with striking eosinophilia with disease progression. The eosinophils showed notable morphological abnormalities (all… read more here.
Keywords: reactive eosinophilia; eosinophil morphology; morphology reactive; hodgkin lymphoma ... See more keywords
Intra‐tumoral and peripheral blood TIGIT and PD‐1 as immune biomarkers in nodular lymphocyte predominant Hodgkin lymphoma
Sign Up to like & getrecommendations! Published in 2024 at "American Journal of Hematology"
DOI: 10.1002/ajh.27459
Abstract: In classical Hodgkin lymphoma (cHL), responsiveness to immune‐checkpoint blockade (ICB) is associated with specific tumor microenvironment (TME) and peripheral blood features. The role of ICB in nodular lymphocyte predominant Hodgkin lymphoma (NLPHL) is not established.… read more here.
Keywords: peripheral blood; intra tumoral; blood; lymphocyte predominant ... See more keywords
Depression and anxiety in Hodgkin lymphoma patients: A Danish nationwide cohort study of 945 patients
Sign Up to like & getrecommendations! Published in 2020 at "Cancer Medicine"
DOI: 10.1002/cam4.2981
Abstract: Cancer‐related psychological distress may lead to depression and anxiety among survivors. The vast majority of patients with Hodgkin lymphoma (HL) become long‐term survivors, but the risk of mental health problems after HL is not well‐characterized.… read more here.
Keywords: risk; hodgkin lymphoma; anxiety; psychotropic drug ... See more keywords
Outcomes associated with allogeneic hematopoietic stem cell transplantation for relapsed and refractory Hodgkin lymphoma in the era of novel agents
Sign Up to like & getrecommendations! Published in 2023 at "Cancer Medicine"
DOI: 10.1002/cam4.5631
Abstract: Relapsed or refractory Hodgkin lymphoma (R/R HL) is a challenging disease with limited treatment options beyond brentuximab vedotin and checkpoint inhibitors. Herein we present the time‐trend analysis of R/R HL patients who received allogeneic hematopoietic… read more here.
Keywords: hodgkin lymphoma; allogeneic hematopoietic; refractory hodgkin; relapsed refractory ... See more keywords
Global burden, risk factors, and trends of non‐Hodgkin lymphoma: A worldwide analysis of cancer registries
Sign Up to like & getrecommendations! Published in 2024 at "Cancer Medicine"
DOI: 10.1002/cam4.7056
Abstract: Non‐Hodgkin lymphoma (NHL) accounts for 90% of all malignant lymphomas. This study aimed to evaluate the global incidence, mortality, associated risk factors, and temporal trends of NHL by sex, age, and country. read more here.
Keywords: non hodgkin; cancer; hodgkin lymphoma; risk factors ... See more keywords
Influence of Survivorship Care on Health‐Related Quality of Life, Knowledge of Late Effects, and Distress Levels Among Long‐Term Hodgkin Lymphoma Survivors
Sign Up to like & getrecommendations! Published in 2025 at "Cancer Medicine"
DOI: 10.1002/cam4.71113
Abstract: Hodgkin lymphoma (HL) is a highly curable malignancy mainly affecting young adults, but survivors are at risk of serious late adverse effects, like cardiovascular disease and subsequent malignancies, which may impact health‐related quality of life… read more here.
Keywords: late effects; survivorship care; related quality; health related ... See more keywords